Level D· Scientific groundwork from lab and animal studiesAnimal StudyEurope PMCOpen access

Depletion of CD40 on CD11c + cells worsens the metabolic syndrome and ameliorates hepatic inflammation during NASH

Aarts S., Reiche M., den Toom M., Gijbels M., Beckers L., Gerdes N.

Animal Study on Type 2 Diabetes, published in Sci Rep (2019) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Sci Rep (2019)
Reported sample size
—
Source database
Europe PMC
PMID
31604965
PMCID
PMC6789104
DOI
10.1038/s41598-019-50976-6
Citations
20

Abstract (original English)

The co-stimulatory CD40-CD40L dyad plays a central role in fine-tuning immune reactions, including obesity-induced inflammation. Genetic ablation of CD40L reduced adipose tissue inflammation, while absence of CD40 resulted in aggravated metabolic dysfunction in mice. During obesity, CD40 expressing CD11c + dendritic cells (DC) and macrophages accumulate in adipose tissue and liver. We investigated the role of CD40 + CD11c + cells in the metabolic syndrome and nonalcoholic steatohepatitis (NASH). DC-CD40-ko mice (CD40 fl/fl CD11c cre ) mice were subjected to obesity or NASH. Obesity and insulin resistance were induced by feeding mice a 54% high fat diet (HFD). NASH was induced by feeding mice a diet containing 40% fat, 20% fructose and 2% cholesterol. CD40 fl/fl CD11c cre mice fed a HFD displayed increased weight gain, increased adipocyte size, and worsened insulin resistance. Moreover, CD40 fl/fl CD11c cre mice had higher plasma and hepatic cholesterol levels and developed profound liver steatosis. Overall, regulatory T cell numbers were decreased in these mice. In NASH, absence of CD40 on CD11c + cells slightly decreased liver inflammation but did not affect liver lipid accumulation. Our experiments suggest that CD40 expressing CD11c + cells can act as a double-edged sword: CD40 expressing CD11c + cells contribute to liver inflammation during NASH but are protective against th

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Dendritic CellsMacrophagesAnimalsMice, KnockoutMiceHepatitisObesityDisease Models, AnimalCD40 LigandMale

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research